首页> 外国专利> ApoA / CII lazy subtypes predicted by atherosclerotic disease

ApoA / CII lazy subtypes predicted by atherosclerotic disease

机译:动脉粥样硬化疾病预测的ApoA / CII惰性亚型

摘要

The invention offers an early detection method for atherosclerosis using genetic analysis to detect polymorphisms shown to be correlated with this disease which are proximal to the apolipoprotein AI (apoAI) and aplipoprotein CIII (apoCIII) gene complex. All individuals with a 300 bp deletion 4kb upstream of the apoAI gene are destined to experience severe atherosclerotic symptomologies. Individuals with a polymorphism 5.4 kb 5' of the apoAI gene or a PvuII polymorphism in the first intron of the apoCIII gene also seem to be at greater risk. A haplotype with MspI and XmnI/7.2 polymorphisms in this general region seen to be protected. Additional polymorphic sites in the DNA sequence associated with the apoAI/CIII gene complex provide a means for genetically fingerprinting individuals, and for identifying persons at risk with respect to disorders relating to lipid metabolism and transport.
机译:本发明提供了使用遗传分析的动脉粥样硬化的早期检测方法,以检测与该疾病相关的多态性,该多态性与载脂蛋白AI(apoAI)和脂蛋白CIII(apoCIII)基因复合体最接近。在apoAI基因上游4kb处有300 bp缺失的所有个体注定会经历严重的动脉粥样硬化症状。具有apoAIIII基因的5.4 kb 5'多态性或apoCIII基因的第一个内含子中的PvuII多态性的个体似乎也处于较高的风险中。在该一般区域中具有MspI和XmnI / 7.2多态性的单倍型被认为是受保护的。与apoAI / CIII基因复合物相关的DNA序列中的其他多态性位点提供了对个体进行基因指纹识别和鉴定与脂质代谢和运输相关的疾病风险的人的手段。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号